参考文献 References
[1] Zhang C, Dong HK, Gao JM, et al. Advances in the diagnosis and treatment of MET-variant digestive tract tumors. World J Gastrointest Oncol. 2024 Nov 15;16(11):4338-4353.
[2] Maoz A, Rodriguez NJ, Yurgelun MB, et al. Gastrointestinal Cancer Precursor Conditions and Their Detection. Hematol Oncol Clin North Am. 2024 Aug;38(4):783-811.
[3] .Diao X, Guo C, Li S. Progress in the Mechanism of Lymphangiogenesis and Lymphatic Metastasis of Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2021 Dec 20;24(12):874-880. Chinese.
[4] Hu Z, Zhao X, Wu Z, et al. Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x. PMID: 38172098; PMCID: PMC10764842.
[5] 郭梦丽.壁虎粗多肽抑制肝癌淋巴管生成的作用及机制研究[D].河南科技大学,2018.
[6] Song CY, Hsieh SL, Yang SY, et al. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma. Int J Mol Sci. 2024 May 9;25(10):5142.
[7] Kawamura K, Lee C, Yoshikawa T, et al. Prediction of cervical lymph node metastasis from immunostained specimens of tongue cancer using a multilayer perceptron neural network. Cancer Med. 2023 Mar;12(5):5312-5322.
[8] Chennakesavalu M, Somala SRR, Dommaraju SR, et al. Corneal6.Song CY, Hsieh SL, Yang SY, Lin CY, Wang SW, Tsai CH, Lo YS, Fong YC, Tang CH. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma. Int J Mol Sci. 2024 May 9;25(10):5142.
[9] Zhang X, Ma L, Xue M, et al. Advances in lymphatic metastasis of non-small cell lung cancer. Cell Commun Signal. 2024 Apr 2;22(1):201. doi: 10.1186/s12964-024-01574-1. PMID: 38566083; PMCID: PMC10986052.
[10] Lin S, Chai Y, Zheng X, et al. The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. Mol Biol Rep. 2023 Dec 12;51(1):14.
[11] Ji H, Hu C, Yang X, et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther. 2023 Sep 27;8(1):367.
[12] Zhang Z, Zhao R, Wu X, et al. Research progress on the correlation between corneal neovascularization and lymphangiogenesis (Review). Mol Med Rep. 2025 Feb;31(2):47.
[13] Mariotti V, Fiorotto R, Cadamuro M, et al. New insights on the role of vascular endothelial growth factor in biliary pathophysiology. JHEP Rep. 2021 Feb 4;3(3):100251. doi: 10.1016/j.jhepr.2021.100251. PMID: 34151244; PMCID: PMC8189933.
[14] Cong B, Cao X, Jiang WG, Ye L. Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer. Onco Targets Ther. 2025 Feb 4;18:199-209.
[15] Dieterich LC, Tacconi C, Ducoli L, et al. Lymphatic vessels in cancer. Physiol Rev. 2022 Oct 1;102(4):1837-1879.
[16] Savetsky IL, Ghanta S, Gardenier JC, et al. Th2 cytokines inhibit lymphangiogenesis. PLoS One. 2015 Jun 3;10(6):e0126908. doi: 10.1371/journal.pone.0126908. PMID: 26039103; PMCID: PMC4454507.
[17] Singla B, Aithbathula RV, Pervaiz N, et al. CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis. Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1234-1250.
[18] Mondal DK, Xie C, Pascal GJ, et al. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression. Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2317760121. doi: 10.1073/pnas.2317760121. Epub 2024 Apr 23. PMID: 38652741; PMCID: PMC11067011.
[19] 赵红博,熊桂宏,李明秋.抑制肿瘤血管淋巴管生成的VEGFR分子机制及调控的研究进展[J].中国医学创新,2023,20(15):184-188.
[20] 周玥莹,曲义坤.过表达趋化因子CXCL1在胃癌中的作用及研究进展[J].中国医药导报,2024,21(05):49-52.
[21] Liu P, Ding P, Sun C, et al. Lymphangiogenesis in gastric cancer: function and mechanism. Eur J Med Res. 2023 Oct 7;28(1):405.
[22] Li Y, Gao X, Huang Y, et al. Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications. Front Oncol. 2023 May 10;13:1114042. doi: 10.3389/fonc.2023.1114042. PMID: 37234990; PMCID: PMC10206119.
[23] Li JJ, Mao JX, Zhong HX, et al. Multifaceted roles of lymphatic and blood endothelial cells in the tumor microenvironment of hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2024 Apr 27;16(4):537-549.
[24] Pal S, Bhowmick S, Sharma A, et al. Lymphatic vasculature in ovarian cancer. Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188950. doi: 10.1016/j.bbcan.2023.188950. Epub 2023 Jul 5. PMID: 37419192; PMCID: PMC10754213.
[25] Lin S, Chai Y, Zheng X, et al. The role of HIF in angiogenesis, lymphangiogenesis, and tumor microenvironment in urological cancers. Mol Biol Rep. 2023 Dec 12;51(1):14.
[26] Kazakova A, Sudarskikh T, Kovalev O, et al. Interaction of tumor associated macrophages with stromal and immune components in solid tumors: Research progress (Review). Int J Oncol. 2023 Feb;62(2):32.
[27] Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017 Feb 25;8(5):761-773. doi: 10.7150/jca.17648. PMID: 28382138; PMCID: PMC5381164.
[28] Xu L, Wang X, Wang B, et al. The global landscape and research trend of lymphangiogenesis in breast cancer: a bibliometric analysis and visualization. Front Oncol. 2024 Mar 14;14:1337124.
[29] Menzel L, Höpken UE, Rehm A. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth. Front Immunol. 2020 Dec 3;11:591741.
[30] Chida K, Oshi M, An N, et al. Gastric cancer with enhanced myogenesis is associated with less cell proliferation, enriched epithelial-to-mesenchymal transition and angiogenesis, and poor clinical outcomes. Am J Cancer Res. 2024 Jan 15;14(1):355-367. doi: 10.62347/NCIM3072. PMID: 38323295; PMCID: PMC10839307.
[31] Park MS, Kim SE, Lee P, et al. Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review. BMB Rep. 2024 Aug;57(8):343-351.
[32] Lampejo AO, Fonseca Perez L, Girgis MM, et al. A Novel in vivo Rat Mesentery Model for Studying Tumor Spheroid-Induced Microvascular Remodeling. J Vasc Res. 2024 Dec 19:1-15.
[33] Schlereth SL, Refaian N, Iden S, et al. Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis. Biomed Res Int. 2014;2014:639058.
[34] Ju W, Cai HH, Zheng W, et al. Cross talk between lymphangiogenesis and malignant melanoma cells: New opinions on tumour drainage and immunization (Review). Oncol Lett. 2024 Jan 5;27(2):81.